Methamphetamine Abuse Treatment in Patients With AIDS - 1
Sponsor
National Institute on Drug Abuse (NIDA) (NIH)
Overall Status
Completed
CT.gov ID
NCT00000321
Collaborator
Friends Research Institute, Inc. (Other)
0
1
62
0
Study Details
Study Description
Brief Summary
The purpose of this study is to evaluate the efficacy of desipramine, sertraline, and placebo on methamphetamine dependent gay men with AIDS.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
| Phase 4 |
Study Design
Study Type:
Interventional
Primary Purpose:
Treatment
Official Title:
Methamphetamine Abuse Pharmacology in Patients With AIDS
Study Start Date
:
Oct 1, 1996
Study Completion Date
:
Dec 1, 2001
Outcome Measures
Primary Outcome Measures
- Craving []
- Retention []
- Depression []
- Methamphetamine use []
- Anxiety and Depression []
- ASI Scales (7) []
- AIDS medical care engagement []
- High risk sexual behaviors []
- Mood indicators []
Eligibility Criteria
Criteria
Ages Eligible for Study:
N/A
and Older
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
No
Please contact site for information.
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Friends Research Institute | Los Angeles | California | United States | 90025 |
Sponsors and Collaborators
- National Institute on Drug Abuse (NIDA)
- Friends Research Institute, Inc.
Investigators
- Principal Investigator: Frank Gawin, M.D., Friends Research Institute, Inc.
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
,
,
ClinicalTrials.gov Identifier:
NCT00000321
Other Study ID Numbers:
- NIDA-10643-1
- R01-10643-1
First Posted:
Sep 21, 1999
Last Update Posted:
Jan 12, 2017
Last Verified:
Oct 1, 1996
Keywords provided by ,
,
Additional relevant MeSH terms: